A case of canine central nervous system cryptococcosis: Management with fluconazole

Journal of the American Animal Hospital Association

Volumn 34, Issue 2, 1998, Pages 145-151

  Tiches, Deena ^a   Vite, Charles H ^a   Dayrell Hart, Betsy ^a   Steinberg, Sheldon A ^a   Gross, Stephen ^a   Lexa, Frank ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE;

ANIMAL MODEL; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DOG; FEMALE; HISTOPATHOLOGY; MENINGOENCEPHALITIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SEIZURE;

ANIMALIA; CANIS FAMILIARIS; FILOBASIDIELLA NEOFORMANS;

EID: 0031951399     PISSN: 05872871     EISSN: None     Source Type: Journal    
DOI: 10.5326/15473317-34-2-145     Document Type: Article

References (25)

1. Malik R, Wigney DI, Muir DB. et al. Cryptococcosis in cats: clinical and mycological assessment of 29 cats and evaluation of treatment using orally administered fiuconazole J Med Vet Mycol 1992;30:133-44.
2. Medleau L. Greene CE, Rakich PM. Evaluation of keioconazok and uraconazole for treatment of disseminated crypiococcosis in cats. Am J Vet Res 1990;51:1454-8.
3. Medleau L, Jacobs GJ, Marks MA Iiraconazole for the treatment of crypiococcosis in cats J Vet Int Med 1995;9(1):39-42.
4. Berthelin CF, Legendre AM, Bailey CS, Kass PH, Wolf AM. Cryptococcosis of the nervous system in dogs, pan 2: diagnosis, treatment, monitoring, and prognosis. Progr Vet Neurol 1994;5(4):136-46
5. Giger U, Jezyk PF. Diagnosis of inherited diseases in small animals In: Kirk RW, Bonagura JD, eds. Current veterinary therapy XI. Philadelphia. WB Saunders, 1992:18-22.
6. Suter PF, Lord PF, eds In: Thoracic radiography: a text atlas of thoracic diseases of the dog and cat. Wettswil. Switzerland Suter, 1984:560-1
7. Heit MC, Riviere JE. Antifungal therapy: ketoconazole and other azole derivatives. Comp Cont Ed Pract Vet 1995;17(1):21-31.
8. Scholer HJ. Diagnosis of Cryptococcosis and monitoring of chemotherapy. Mykosen 1985;28(1):5-16.
9. Jacobs GJ, Medleau L, Calvert C, Brown J Cryptococcal infection in cats: factors influencing treatment outcome, and the results of sequential serum antigen titers in 35 cats. J Vet Int Med 1997;11(1):1-4
10. Bennett JE, Dismukes WE, Duma RJ, et al. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. New Engl J Med 1979;301:126-31.
11. Perfect JR, Savani DV, Durack DT Comparison of itraconazole and fluconazole in the treatment of cryptoeoccal meningitis and Candida pyelonephritis in rabbits Antimicrob Agents Chemother 1986;29:579-83.
12. Palou de Fernandez E, Patino MM, Graybill JR, et al. Treatment of cryptococcal meningitis in mice with fluconazole. J Antimicrob Chemother 1986;18:261-70
13. Malik R, Dill-Macky E, Wigney DI, Muir DB, Love DN. Cryptococcosis in dogs: a retrospective study of 20 consecutive cases. J Med Vet Mycology 1995;33:291-7.
14. Brammer KW, Farrow PR, Faulkner JK. Pharmacokinetics and tissue penetration of fluconazole in humans. Rev Infect Dis 1990;12(Suppl 3):318-26.
15. Arndt CA, Walsh TJ, McCully CL, Balis FM, Pizzo PA, Poplack DG, Fluconazole penetration into cerebrospmal fluid: implications for treating fungal infections of the central nervous system J Infect Dis 1988;157(1):178-80.
16. Humphrey MJ, Jevons S, Tarbit MH Pharmacokmetic evaluation of UK-49.858. a metabolically stable triazoie antifungal drug, in animals and humans Antimicrob Agents Chemother 1985;28:648-53
17. Bailey EM, Krakovsky DJ, Rybak MJ The triazole antifungal agents: a review of itraconazole and fluconazole. Pharmacotherapy 1990;10(2):146-53.
18. Munoz P, Moreno S, Berenguer J. et al Fluconazole-related hepatotoxicity in patients with acquired immunodeficiency syndrome Arch Int Med 1991;151:1020-1.
19. Andreula CF, Burdi N, Cadella A, CNS cryptococcosis in AIDS: spectrum of MR findings J Comput Assist Tomogr 1993;17(3):438-41.
20. Tien RD, Chu PK, Hesselink JR. et al Intracramal cryptococcosis in immunocompromised patients. CT and MRI findings in 29 cases. Am J Neurol Radiol 1991;12:283-9.
21. Fujata NK, Reynard M, Sapico FL. et al Cryptococcal intracerebral mass lesions the role of computed tomography and nonsurgical management. Ann Int Med 1981;94:382-8
22. Chrisman C In: Problems in small animal neurology 2nd ed. Philadelphia-Lea & Febiger, 1991:193
23. Berthelin CF, Bailey CS, Kass PH, Legendre AM, Wolf AM. Cryptococcosis of the nervous system in dogs, part I epidemiologic. clinical, and neuropathologic features Prog Vet Neurol 1994;5(3):88-97.
24. Chfford DH, Pirsch JG, Mauldin ML Comparison of motor nuclei of the vagus nerve in dogs with and without esophageal achalasia. Proceed. Soc Exper Biol Med 1973;142:878-82
25. Higgs B, Kerr FW, Ellis FH. The experimental production of esophageal achalasia by electrolytic lesions in the medulla. J Thoracic Cardiovasc Surg 1965;50:613-25.